Dana Faratian

Division of Pathology, University of Edinburgh

Research Area

Biography

Dana Faratian has not added Biography.
If you are Dana Faratian and would like to personalize this page please email our Author Liaison for assistance.

JoVE Journal Publications

ArticleTotal : 2	Year
Publication title Cited by 27	2011
Publication title Cited by 12	2013

Other Publications

Article	Year
Estrogen-independent proliferation is present in estrogen-receptor HER2-positive primary breast cancer after neoadjuvant letrozole. Journal of clinical oncology : official journal of the American Society of Clinical Oncology\| PubMed ID: 16754938	2006
DCIS and aromatase inhibitors. The Journal of steroid biochemistry and molecular biology\| PubMed ID: 17604618	2007
Dynamic computational modeling in the search for better breast cancer drug therapy. Pharmacogenomics\| PubMed ID: 18086005	2007
Diesel exhaust inhalation increases thrombus formation in man. European heart journal\| PubMed ID: 18952612	2008
Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma. Histopathology\| PubMed ID: 19207951	2009
Pleural Wegener's granulomatosis: a rare presentation. Histopathology\| PubMed ID: 19236522	2009
PPM1D is a potential therapeutic target in ovarian clear cell carcinomas. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 19293255	2009
Rapid screening of tissue microarrays for Her-2 fluorescence in situ hybridization testing is an accurate, efficient and economic method of providing an entirely in situ hybridization-based ... Histopathology\| PubMed ID: 19309394	2009
Systems pathology--taking molecular pathology into a new dimension. Nature reviews. Clinical oncology\| PubMed ID: 19581910	2009
Systems biology reveals new strategies for personalizing cancer medicine and confirms the role of PTEN in resistance to trastuzumab. Cancer research\| PubMed ID: 19638581	2009
Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Proceedings of the National Academy of Sciences of the United States of America\| PubMed ID: 19666588	2009
Modulation of HER3 is a marker of dynamic cell signaling in ovarian cancer: implications for pertuzumab sensitivity. Molecular cancer research : MCR\| PubMed ID: 19737968	2009
How can systems pathology help us personalize cancer therapy? Discovery medicine\| PubMed ID: 19788873	2009
The importance of growth factors and steroid hormones in ovarian cancer. Onkologie\| PubMed ID: 19887864	2009
Automated image analysis for high-throughput quantitative detection of ER and PR expression levels in large-scale clinical studies: the TEAM Trial Experience. Histopathology\| PubMed ID: 19912364	2009
COX2 表达式在预后和预测内分泌治疗的早期乳腺癌患者。 Breast cancer research and treatment\| PubMed ID: 20358279	2011
Pertuzumab for the treatment of ovarian cancer. Expert opinion on biological therapy\| PubMed ID: 20465533	2010
Dynamic changes in gene expression in vivo predict prognosis of tamoxifen-treated patients with breast cancer. Breast cancer research : BCR\| PubMed ID: 20569502	2010
Cancer systems biology. Methods in molecular biology (Clifton, N.J.)\| PubMed ID: 20824475	2010
Tyrosine phosphorylation profiling reveals the signaling network characteristics of Basal breast cancer cells. Cancer research\| PubMed ID: 20861192	2010
Compensatory effects in the PI3K/PTEN/AKT signaling network following receptor tyrosine kinase inhibition. Cellular signalling\| PubMed ID: 20951800	2011
Systems pathology. Breast cancer research : BCR\| PubMed ID: 21172088	2010
Phosphoprotein pathway profiling of ovarian carcinoma for the identification of potential new targets for therapy. European journal of cancer (Oxford, England : 1990)\| PubMed ID: 21334202	2011
Higher incidence of isolated brain metastases in ovarian cancer patients with previous early breast cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society\| PubMed ID: 21370594	2010
What can molecular pathology contribute to the management of renal cell carcinoma? Nature reviews. Urology\| PubMed ID: 21487387	2011
Trastuzumab and pertuzumab produce changes in morphology and estrogen receptor signaling in ovarian cancer xenografts revealing new treatment strategies. Clinical cancer research : an official journal of the American Association for Cancer Research\| PubMed ID: 21571868	2011
Two possible mechanisms of epithelial to mesenchymal transition in invasive ductal breast cancer. Clinical & experimental metastasis\| PubMed ID: 21789718	2011
Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients. Breast cancer research and treatment\| PubMed ID: 21796367	2011
Sprouty 2 is an independent prognostic factor in breast cancer and may be useful in stratifying patients for trastuzumab therapy. PloS one\| PubMed ID: 21909357	2011
Features of the reversible sensitivity-resistance transition in PI3K/PTEN/AKT signalling network after HER2 inhibition. Cellular signalling\| PubMed ID: 21996585	2012
GnRH receptor activation competes at a low level with growth signaling in stably transfected human breast cell lines. BMC cancer\| PubMed ID: 22051164	2011
Model-based global sensitivity analysis as applied to identification of anti-cancer drug targets and biomarkers of drug resistance in the ErbB2/3 network. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences\| PubMed ID: 22085636	2011
Validation of activated caspase-3 antibody staining as a marker of apoptosis in breast cancer. Histopathology\| PubMed ID: 22168172	2012
The use of automated quantitative analysis to evaluate epithelial-to-mesenchymal transition associated proteins in clear cell renal cell carcinoma. PloS one\| PubMed ID: 22363672	2012
HER2 expression in ovarian carcinoma: caution and complexity in biomarker analysis. Journal of clinical pathology\| PubMed ID: 22412045	2012
Diversity of matriptase expression level and function in breast cancer. PloS one\| PubMed ID: 22514623	2012
Feedforward and feedback regulation of the MAPK and PI3K oscillatory circuit in breast cancer. Cellular signalling\| PubMed ID: 23000339	2013
Transcript and protein profiling identify signaling, growth arrest, apoptosis and NFÎºB-survival signatures following GnRH receptor activation. Endocrine-related cancer\| PubMed ID: 23202794	2012